U.S. Markets close in 54 mins

AbbVie Stock Dropped After FDA Warning. Analysts Say Selloff Is Overblown.

·4 min read
AbbVie Stock Dropped After FDA Warning. Analysts Say Selloff Is Overblown.
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

The regulator said a class of drug known as JAK inhibitors increased the risk of cancer, serious heart-related events, and death.